A Comprehensive Monograph on Hypromellose (DB11075): Physicochemical Properties, Pharmaceutical Applications, and Safety Profile

1.0 Executive Summary

Hypromellose, also known by its chemical name hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer derived from cellulose. It stands as a cornerstone of modern pharmaceutical science due to its remarkable versatility, functioning as both a primary therapeutic agent in ophthalmic formulations and an indispensable excipient in a vast array of oral and topical drug delivery systems.[1] This monograph provides a comprehensive analysis of Hypromellose, integrating its physicochemical characteristics, pharmacological mechanisms, pharmacokinetic profile, clinical applications, and safety data. The fundamental utility of Hypromellose is rooted in a predictable structure-function paradigm, where its molecular properties—specifically the degree of chemical substitution and polymer chain length—can be precisely modulated to control macroscopic behaviors such as viscosity, hydration rate, and thermal gelation. This tunability allows for the engineering of specific performance outcomes, from providing gentle, long-lasting lubrication for the ocular surface to orchestrating the complex, zero-order release of active pharmaceutical ingredients from once-daily oral tablets.

As an ophthalmic demulcent, Hypromellose provides symptomatic relief for dry eye disease by physically stabilizing and thickening the precorneal tear film, thereby increasing its residence time and protecting the ocular surface from desiccation.[2] In its role as a pharmaceutical excipient, it is the most widely used polymer for fabricating hydrophilic matrix systems for controlled-release oral dosage forms. Upon ingestion, it hydrates to form a viscous gel barrier that meticulously regulates drug release through mechanisms of diffusion and matrix erosion.[5] Its pharmacokinetic profile is characterized by a profound biological inertness; it is not absorbed systemically, is not metabolized, and is excreted unchanged, a critical asset that ensures its safety and prevents interference with the active drugs it is designed to deliver.[7] This exceptional safety profile is corroborated by extensive preclinical toxicology data and underpins its global regulatory acceptance by agencies such as the U.S. Food and Drug Administration (FDA) and its widespread use in non-pharmaceutical sectors, including the food, cosmetics, and construction industries.[7] This report elucidates the multifaceted nature of Hypromellose, establishing it as a highly refined and essential tool in pharmaceutical formulation and therapy.

2.0 Identification and Physicochemical Profile

2.1 Nomenclature and Chemical Identity

Hypromellose is a semisynthetic cellulose ether, formally defined as a partly O-methylated and O-(2-hydroxypropylated) derivative of cellulose.[6] Its nonproprietary name, as designated by the International Nonproprietary Names (INN) system, is Hypromellose.[1] It is also widely known by its chemical name, Hydroxypropyl Methylcellulose (HPMC), and other synonyms such as Cellulose hydroxypropyl methyl ether and (Hydroxypropyl)methyl cellulose.[1]

It is assigned several key identifiers for regulatory and scientific tracking:

• CAS Number: 9004-65-3 [11]
• DrugBank ID: DB11075 [11]
• E Number (Food Additive): E464 [1]

The fundamental chemical structure of Hypromellose is based on the natural polysaccharide cellulose, which consists of repeating beta-linked D-glucose units. In the synthesis of Hypromellose, alkali cellulose is reacted with methyl chloride and propylene oxide, resulting in the substitution of the hydroxyl groups on the glucose rings with methoxy (–OCH3​) and 2-hydroxypropoxy (–OCH2​CH(OH)CH3​) groups.[13] The distribution of these substituent groups along the cellulose backbone is not entirely uniform, but the resulting polymer exhibits consistent and predictable properties based on the average degree of substitution.[16] While the exact molecular formula and weight vary depending on the specific grade (i.e., the degree of substitution and the length of the polymer chain), a representative chemical formula often cited is

C56​H108​O30​.[12]

2.2 Physical and Chemical Properties

Hypromellose is characterized by a unique set of physical and chemical properties that are central to its wide-ranging applications.

• Appearance: In its raw form, Hypromellose is an odorless and tasteless, white to slightly off-white or beige, fibrous or granular, free-flowing powder.[1]
• Solubility: The polymer displays distinctive solubility behavior. It is soluble in cold water, where it hydrates and swells to form a viscous, transparent to opalescent colloidal solution.[1] Conversely, it is insoluble in hot water, a property that is exploited in its manufacturing and purification.[10] It is also practically insoluble in certain organic solvents like absolute ethanol and chloroform but is soluble in polar organic solvent systems, such as mixtures of water and alcohol.[14]
• Thermal Gelation: A hallmark characteristic of aqueous Hypromellose solutions is reversible thermal gelation. When a solution is heated to a critical temperature, typically between 75 °C and 90 °C, the polymer loses its hydration shell, leading to increased polymer-polymer interactions and the formation of a semi-flexible, non-flowable gel. This process is fully reversible; the solution returns to its original fluid state upon cooling.[1] The precise gelation temperature is influenced by the polymer grade, specifically the ratio of methoxy to hydroxypropyl groups, and the polymer concentration in the solution.[1]
• Stability: Hypromellose is a stable compound, particularly within a pH range of 3 to 11, which makes it compatible with the physiological environments of the eye and the gastrointestinal tract, as well as a wide variety of formulation conditions.[10] Its aqueous solutions are also resistant to enzymatic degradation, contributing to good viscosity stability during long-term storage.[10]
• Other Properties: It is a non-toxic and physiologically inert material.[7] As a solid, it is combustible and can react with strong oxidizing agents.[1] It has a charring temperature of approximately 225–230 °C.[13] Being a hygroscopic powder, it will absorb moisture from the atmosphere if not stored in a well-closed container in a cool, dry place.[10]

Table 1: Key Physicochemical Properties of Hypromellose

Property	Value / Description	Reference(s)
Appearance	White to slightly off-white/beige, odorless, tasteless, fibrous or granular powder	1
Solubility	Soluble in cold water; insoluble in hot water, absolute ethanol, chloroform	10
pH Stability	Stable in aqueous solutions with a pH between 3.0 and 11.0	10
Thermal Behavior	Exhibits reversible thermal gelation; chars at 225–230 °C	1
Hygroscopicity	Hygroscopic; absorbs moisture from the air	14
Chemical Reactivity	Incompatible with strong oxidizing agents	10

2.3 Polymer Characteristics: Viscosity, Substitution, and Molecular Weight

Hypromellose is not a single chemical entity but rather a family of polymers available in numerous grades. These grades are differentiated by three critical and interconnected molecular characteristics: the degree of substitution (DS), the molar substitution (MS), and the average molecular weight (or degree of polymerization).[14] The interplay of these factors dictates the polymer's physicochemical properties, most notably its viscosity, which in turn governs its functional performance in any given application. This direct and predictable relationship between molecular structure and macroscopic function is the cornerstone of its utility as a pharmaceutical material.

The degree of substitution refers to the average number of hydroxyl groups on each glucose unit of the cellulose backbone that have been replaced by substituent groups. For Hypromellose, this is further specified: the DS indicates the average number of methoxy groups, while the MS refers to the average number of hydroxypropyl groups per glucose unit.[14] The United States Pharmacopeia (USP) employs a four-digit numbering system to denote the substitution type. For instance, "Hypromellose 2910" indicates a polymer with an approximate methoxy content of 28.0–30.0% and a hydroxypropoxy content of 7.0–12.0%. In contrast, "Hypromellose 2208" has a methoxy content of 19.0–24.0% and a hydroxypropoxy content of 4.0–12.0%.[10] This ratio of hydrophobic methoxy groups to more hydrophilic hydroxypropyl groups is a key determinant of the polymer's hydration rate, solubility, and thermal gelation temperature.[14]

Of all its properties, viscosity is the most important functional characteristic of Hypromellose. It is a direct consequence of the polymer's average molecular weight and chain length; longer polymer chains lead to greater molecular entanglement in solution, resulting in higher viscosity.[19] Pharmaceutical grades of Hypromellose are available across an exceptionally broad range of viscosities, from as low as 3 mPa·s to over 100,000 mPa·s (measured as a 2% w/w aqueous solution at 20 °C).[3] This extensive range allows formulators to select a specific grade to achieve a desired performance characteristic with high precision. For example, high-viscosity grades (e.g., K100M, with a viscosity of ~100,000 mPa·s) are chosen for controlled-release oral tablets because they form a robust, slow-eroding gel barrier. In contrast, low-viscosity grades (e.g., E5, with a viscosity of ~5 mPa·s) are used for ophthalmic solutions to provide lubrication and increase residence time without causing excessive, prolonged blurring of vision.[4] This ability to fine-tune performance by selecting a polymer with a specific molecular weight and viscosity profile exemplifies the structure-function paradigm that makes Hypromellose such a versatile and powerful tool in pharmaceutical science.

Table 2: Pharmaceutical Grades of Hypromellose: Substitution Type, Molecular Weight, and Viscosity

Substitution Type	Grade Name	Weight Average Molecular Weight (approx.)	Nominal Viscosity (mPa·s) at 2% Solution
Hypromellose 2910 ("E" types)	E4M Pharm	400,000	2,700–5,040
	E10M Pharm	746,000	7,500–14,000
Hypromellose 2208 ("K" types)	K100LV PH PRM	164,000	80–120
	K250 PH PRM	200,000	200–300
	K750 PH PRM	250,000	562–1,050
	K1500 PH PRM	300,000	1,125–2,100
	K4M Pharm	400,000	2,700–5,040
	K15M Pharm	575,000	13,500–25,200
	K35M Pharm	675,000	26,250–49,000
	K100M Pharm	1,000,000	75,000–140,000
	K200M Pharm	1,200,000	150,000–280,000
Data compiled from Ashland Benecel™ HPMC product specifications.21

3.0 Pharmacology and Mechanism of Action

Hypromellose is considered a pharmacologically inert substance, meaning it does not exert its effects through classical receptor-mediated pathways or biochemical interactions within the body.[2] Instead, its utility in medicine is derived entirely from its physical properties and its ability to modulate the local environment where it is applied. Its mechanism of action differs based on its intended application, primarily as an ophthalmic demulcent or as a pharmaceutical excipient in drug delivery systems.

3.1 Ophthalmic Demulcent Action

In ophthalmic applications, Hypromellose functions as an artificial tear, providing lubrication and protection to the ocular surface.[2] Its mechanism is purely physical and is designed to supplement or replace the natural tear film in conditions of dryness. The natural tear film is a complex, three-layered structure, and Hypromellose primarily acts as a substitute for the innermost mucous (mucin) layer.[4] The mucin layer is responsible for adhering the aqueous layer of the tears to the relatively hydrophobic corneal epithelium, allowing for even spreading and stability of the tear film.[2]

Upon instillation into the eye, the Hypromellose solution forms a moist, protective film over the cornea and conjunctiva. Its key actions include:

1. Lubrication and Protection: The viscous nature of the solution lubricates the eye, reducing the friction between the eyelid and the cornea during blinking. This alleviates symptoms of irritation, burning, itching, and the sensation of a foreign body in the eye.[2]
2. Increased Residence Time: The viscosity-promoting properties of Hypromellose are crucial for its efficacy. By increasing the viscosity of the tear film, it slows the drainage of tears from the ocular surface and reduces the rate of evaporation.[2] This prolongs the contact time of the lubricant on the eye, leading to a longer tear film breakup time and providing more sustained relief compared to less viscous solutions or natural tears in a deficient state.[2]
3. Corneal Wetting and Hydration: The polymer swells and absorbs water, effectively increasing the thickness of the precorneal tear film.[1] This enhanced hydration barrier protects the corneal epithelial cells from damage caused by desiccation.[2] DrugBank identifies the target of this action as the Epithelial Cell Adhesion Molecule, suggesting that Hypromellose interacts at the cell surface to promote adhesion of the moisture film.[2]

The formulation is typically isotonic and pH-balanced to match natural tears, minimizing the potential for irritation upon application.[4] The relief provided is generally felt within minutes and can last for several hours, depending on the concentration and viscosity of the specific product used.[4]

3.2 Mechanism as a Controlled-Release Excipient

In oral solid dosage forms, Hypromellose is the most commonly employed polymer for the fabrication of hydrophilic matrix tablets, a technology designed to provide controlled or sustained release of an active pharmaceutical ingredient (API).[5] The mechanism of action is a dynamic process involving hydration, swelling, and the formation of a gel barrier that meticulously controls the rate of drug release.

The process begins upon ingestion, when the tablet comes into contact with the aqueous fluids of the gastrointestinal tract. The Hypromellose polymer on the surface of the tablet rapidly hydrates and swells, transforming from a dry powder into a viscous, gelatinous layer that encases the dry core of the tablet.[5] This gel layer serves as a dynamic physical barrier that prevents the immediate disintegration of the tablet and governs the subsequent release of the API.[6]

Drug release from this hydrophilic matrix is controlled by two primary, often simultaneous, mechanisms [6]:

1. Diffusion: Water from the gastrointestinal fluid permeates the gel layer, dissolving the API within the matrix. The dissolved drug molecules then diffuse outward through the tortuous aqueous channels of the gel layer into the surrounding fluid. The rate of diffusion is governed by Fick's law and depends on the drug's solubility, the thickness of the gel layer, and the tortuosity of the diffusion path.
2. Erosion: As the outer surface of the gel layer becomes fully hydrated, it begins to slowly dissolve or erode into the gastrointestinal lumen. This process of matrix erosion physically releases the embedded drug particles.

The relative contribution of diffusion versus erosion depends largely on the solubility of the API. For highly water-soluble drugs, diffusion through the gel layer is the predominant release mechanism. For poorly soluble drugs, release is primarily dependent on the rate of matrix erosion.[6] The rate of drug release can be precisely engineered by selecting a specific grade of Hypromellose. Higher viscosity grades, which have a higher molecular weight, form a stronger, more resilient gel layer that hydrates and erodes more slowly. This results in a slower, more prolonged drug release profile, making it possible to design formulations for once-daily administration, thereby improving patient compliance and providing more stable therapeutic effects.[2]

3.3 Ancillary Pharmaceutical Functions

Beyond its two primary roles, the versatile properties of Hypromellose allow it to serve several other important functions as a pharmaceutical excipient:

• Binder: In the manufacturing of tablets via wet or dry granulation, Hypromellose acts as a binder. Its adhesive properties help to agglomerate powdered ingredients, providing the necessary cohesive strength to form robust granules and, ultimately, tablets that can withstand the rigors of handling and packaging.[1]
• Film-Coating Agent: Low-viscosity grades of Hypromellose are widely used to form aqueous film coatings on tablets and capsules. When dissolved and sprayed onto the dosage form, the polymer forms a thin, uniform, tough, and elastic film as the solvent evaporates. This coating can serve multiple purposes: protecting the API from light or moisture, masking an unpleasant taste or odor, improving the aesthetic appearance of the tablet, and facilitating easier swallowing.[1]
• Thickening and Suspending Agent: In liquid and semi-solid formulations, such as oral suspensions or topical gels, Hypromellose is used as a rheology modifier. It increases the viscosity of the formulation, which helps to keep insoluble drug particles suspended uniformly, preventing them from settling over time and ensuring consistent dosing.[1]
• Solubility Enhancer: In advanced drug delivery technologies like solid dispersions, Hypromellose can act as a carrier matrix to improve the dissolution rate and bioavailability of poorly water-soluble drugs. By dispersing the drug at a molecular level within the hydrophilic polymer matrix, it prevents drug crystallization and enhances its wettability and dissolution in aqueous fluids.[2]

4.0 Pharmacokinetic Profile

4.1 Absorption, Distribution, Metabolism, and Excretion (ADME)

The pharmacokinetic profile of Hypromellose is defined by its profound biological inertness. It is a high-molecular-weight polymer that is not recognized by biological transport systems and is resistant to enzymatic degradation in the human body. Consequently, it does not undergo the typical pharmacokinetic processes of absorption, distribution, metabolism, and excretion (ADME) associated with systemically active drugs.[2] This lack of systemic exposure is not merely a passive characteristic but a critical feature that underpins its exceptional safety profile and its utility as a pharmaceutical excipient.

• Absorption: Following topical ocular administration or oral ingestion, Hypromellose is not significantly absorbed into the systemic circulation.[7] When applied to the eye, it remains on the ocular surface to exert its lubricating effect before being cleared through the nasolacrimal duct. When administered orally, it passes through the gastrointestinal tract without crossing the intestinal mucosa. Preclinical studies conducted in rats using radiolabeled Hypromellose demonstrated that oral bioavailability is negligible, with approximately only 1% of an administered dose being absorbed, while the remainder is excreted in the feces.[7] The large molecular size of the polymer precludes passive diffusion across biological membranes, and it is not a substrate for active transport mechanisms.[32]
• Distribution: As systemic absorption is negligible, there is no subsequent distribution of Hypromellose throughout the body's tissues and organs. The polymer remains localized to its site of administration—either the ocular surface or the lumen of the gastrointestinal tract.[8]
• Metabolism: Hypromellose is not metabolized by human enzymes in the gastrointestinal tract or elsewhere in the body.[7] It is a chemically modified cellulose polymer that is resistant to hydrolysis by digestive enzymes.
• Excretion: After oral administration, Hypromellose is quantitatively excreted unchanged in the feces.[7]

This complete lack of systemic exposure and biological activity is a fundamental asset, particularly in its role as an excipient. Pharmaceutical formulations, especially controlled-release matrix tablets, can contain a high proportion of Hypromellose, often exceeding the mass of the active drug itself.[5] If this polymer were to be absorbed or metabolized, it would introduce a host of complexities, including the potential for systemic toxicity, drug-drug interactions with the API, and the need for extensive characterization of its own ADME profile. Its biological inertness eliminates these concerns, allowing formulators to use it as a predictable, non-interfering "chassis" for drug delivery. This inherent safety is the primary reason why Hypromellose is classified as "Generally Regarded As Safe" (GRAS) by regulatory bodies like the FDA and has achieved widespread global acceptance in pharmaceutical, food, and cosmetic products.[9]

5.0 Clinical and Non-Clinical Applications

The unique physicochemical properties of Hypromellose have led to its adoption in a diverse range of applications, spanning from therapeutic medicine and advanced drug delivery to consumer products and industrial materials. Its primary value lies in its ability to control hydration and modify rheology in a safe and predictable manner.

5.1 Ophthalmic Applications

In the field of ophthalmology, Hypromellose is utilized in several distinct clinical capacities, both as a therapeutic agent and as a procedural aid.

5.1.1 Therapeutic Management of Dry Eye Disease

The principal therapeutic indication for Hypromellose is the symptomatic management of dry eye disease, also known as keratoconjunctivitis sicca.[25] It is a first-line treatment, available over-the-counter, for relieving the discomfort associated with insufficient tear production or excessive tear evaporation. Common causes of dry eyes that are managed with Hypromellose include environmental factors (e.g., wind, sun, prolonged computer use, air conditioning), underlying medical conditions (e.g., Sjögren's syndrome, rheumatoid arthritis), and side effects from certain systemic medications.[25] A clinical study involving patients with moderate-to-severe dry eye syndrome demonstrated the efficacy of a 0.3% Hypromellose gel. After four weeks of treatment, patients experienced a statistically significant reduction of approximately 40% in key symptoms such as dryness, stinging, and foreign body sensation. Furthermore, the objective measure of tear film stability, the tear breakup time, increased by 59% from baseline, confirming the polymer's ability to stabilize the precorneal tear film.[38]

5.1.2 Role as a Viscoelastic Surgical Aid

Higher concentration formulations of Hypromellose (typically 2% intraocular solution) serve as an essential ophthalmic viscoelastic device (OVD) during anterior segment surgeries, most notably cataract extraction and intraocular lens (IOL) implantation.[1] During these delicate procedures, the viscoelastic solution is injected into the anterior chamber of the eye to:

• Maintain the depth and shape of the anterior chamber, preventing its collapse and providing adequate space for surgical manipulation.[39]
• Protect the sensitive corneal endothelium and other intraocular tissues from mechanical damage caused by surgical instruments and the IOL itself.[15]
• Allow for easier and more controlled manipulation of tissues within the eye.[15]

5.1.3 Diagnostic and Supportive Uses

Hypromellose also plays a supportive role in various ophthalmic procedures and for patient care:

• Gonioscopy: It is used as a coupling fluid during gonioscopy, an examination of the eye's drainage angle, to provide a clear view while protecting the corneal surface.[2]
• Contact Lens and Prosthetic Care: It can be used to moisten and lubricate hard contact lenses and ocular prosthetics (artificial eyes), enhancing comfort for the wearer.[26]

5.2 Applications in Oral Drug Delivery Systems

Hypromellose is arguably one of the most important and widely used excipients in the formulation of oral solid dosage forms, where its primary function is to control the release of the active drug.

5.2.1 Design of Controlled and Sustained-Release Formulations

This application represents the most significant use of Hypromellose in the pharmaceutical industry. It is the polymer of choice for creating hydrophilic matrix systems, which are designed to release a drug in a controlled, predictable manner over an extended period.[1] This technology enables the development of once-daily or twice-daily medications, which can improve patient adherence and maintain more stable plasma drug concentrations, prolonging therapeutic effects and potentially reducing side effects.[2] Numerous drugs have been successfully formulated in Hypromellose-based sustained-release matrices, including the beta-blocker Metoprolol Succinate.[42]

5.2.2 Utility in Immediate-Release Formulations

While renowned for its role in controlled release, Hypromellose is also a common component in conventional immediate-release tablets and capsules. In these formulations, it typically serves as a binder to ensure tablet integrity or as a film-forming agent for tablet coatings.[1] An extensive list of widely used medications, including analgesics (Acetaminophen, Ibuprofen), antihistamines (Cetirizine), and proton pump inhibitors (Pantoprazole), utilize Hypromellose for these purposes.[42]

5.3 Applications Beyond Pharmaceuticals

The safety, versatility, and unique physical properties of Hypromellose have led to its widespread adoption in several non-pharmaceutical industries:

• Food Industry: Under the E number E464, it is approved for use as a multipurpose food additive. It functions as an emulsifier, thickening agent, stabilizer, and suspending agent.[1] It is also used as a vegetarian and vegan alternative to animal-derived gelatin in food products and capsule shells. Research is ongoing to explore its potential as a gluten substitute in baking, where its ability to trap gas bubbles can help bread to rise.[1]
• Cosmetics and Personal Care: Hypromellose is a common ingredient in a wide range of personal care products. In skin care items like moisturizers and sunscreens, it acts as a film-former to help prevent moisture loss. In hair care products such as shampoos and conditioners, it serves as a thickener and helps to improve texture and add volume. It is also used in color cosmetics like foundations to enhance consistency and stability.[13]
• Construction Industry: In construction materials, particularly tile adhesives, renders, and plasters, Hypromellose is used as a rheology modifier and a water retention agent. It improves the workability of the material, prevents premature drying, and enhances adhesion.[1]

5.4 Insights from Clinical Research

The clinical relevance of Hypromellose continues to be an area of active investigation. It has been included as an excipient in several completed Phase 4 clinical trials for combination therapies aimed at treating glaucoma and ocular hypertension. These studies evaluated formulations containing active drugs such as Bimatoprost, Brimonidine, and Timolol, underscoring the critical role of Hypromellose as a vehicle in the development of advanced ophthalmic medications.[43] Additionally, ongoing Phase 2 trials are further exploring its efficacy in the treatment of Dry Eye Syndrome, sometimes in novel contexts, such as in comparison to Traditional Chinese Medicine, indicating a continued interest in optimizing its therapeutic use.[44] This body of research confirms the dual importance of Hypromellose: as a standalone therapeutic agent for common ocular conditions and as a foundational component for enabling the delivery of other potent ophthalmic drugs.

6.0 Safety, Tolerability, and Regulatory Information

6.1 Adverse Event Profile

Hypromellose is widely regarded as a safe and well-tolerated substance, with a low incidence of adverse effects, particularly given its lack of systemic absorption. The majority of reported side effects are localized to the site of application and are typically mild and transient in nature.

When used as an ophthalmic solution, the most frequently reported adverse events include [4]:

• Temporary blurred vision immediately following instillation.
• Minor and temporary burning, stinging, or irritation in the eye.

These effects usually resolve within a few minutes as the solution spreads across the ocular surface. Less common, but more significant, side effects that should prompt discontinuation of use and consultation with a healthcare professional include [25]:

• Persistent or worsening eye pain.
• Changes in vision.
• Continued or increased eye redness and irritation.
• Puffy or droopy eyelids.
• The development of a lump or swelling in the eyelid.

Systemic side effects are not an expected outcome of either ophthalmic or oral use due to the polymer's inertness and lack of absorption.[31] A very serious allergic (hypersensitivity) reaction is rare but possible. Symptoms may include rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, and difficulty breathing, which require immediate medical attention.[25]

6.2 Contraindications, Warnings, and Precautions

The primary contraindication for the use of Hypromellose is a known history of hypersensitivity or allergy to Hypromellose itself or to any of the other inactive ingredients present in the specific formulation.[31]

A significant area of precaution revolves around the use of preservatives in multi-dose ophthalmic preparations. Many commercially available Hypromellose eye drops contain benzalkonium chloride (BAK) to maintain sterility after the bottle is opened.[26] This presents a clinical challenge, as BAK is a known cytotoxic agent that can be detrimental to the ocular surface, especially with long-term, frequent use. It can disrupt the stability of the tear film and cause damage to the corneal and conjunctival epithelial cells, potentially exacerbating the very symptoms of dry eye that the product is intended to treat.[31] Furthermore, BAK is known to be absorbed by soft contact lenses, which can lead to lens discoloration and act as a reservoir for the preservative, prolonging its contact with the eye and increasing the risk of irritation.[31] This "preservative dilemma" has been a major driver for innovation in ophthalmic formulations, leading to the development and increased recommendation of preservative-free Hypromellose products, which are typically packaged in single-use vials to ensure sterility. For patients with moderate-to-severe dry eye, those who require frequent dosing, or those who wear contact lenses, preservative-free formulations are considered the clinically superior option.

General precautions for patients using Hypromellose ophthalmic products include:

• Contact Lens Wear: Patients wearing soft contact lenses should remove them before instilling drops containing preservatives like BAK and wait at least 15 minutes before reinserting them.[31]
• Visual Disturbance: Due to the potential for temporary blurred vision, patients should be advised not to drive, operate heavy machinery, or perform any activity requiring clear vision until their sight has cleared.[25]
• Product Appearance: The solution should not be used if it has changed color or become cloudy, as this may indicate contamination or degradation.[25]
• Contamination: To avoid contamination of the product and the eye, the tip of the dropper should not touch the eye or any other surface.[25]

6.3 Drug Interaction Profile

Due to its lack of systemic absorption, Hypromellose is not associated with any systemic drug-drug interactions.[47] The only clinically relevant interaction is a local, pharmacodynamic one that occurs within the eye. By increasing the viscosity of the tear film, Hypromellose can prolong the residence time of other concurrently administered topical ophthalmic medications on the ocular surface.[26] This may potentially enhance the absorption and therapeutic effect of the other drug. To manage this interaction and ensure proper absorption of all medications, it is generally recommended that patients wait at least 5 to 10 minutes between the application of different eye drops.[25]

6.4 Preclinical Toxicology Summary

The safety of Hypromellose is well-established through extensive use and a comprehensive body of preclinical toxicology data, which consistently demonstrates its low toxicity and non-irritant nature.[7]

• Acute Toxicity: The acute oral toxicity of Hypromellose is exceptionally low. The median lethal dose (LD50) in rats is greater than 10,000 mg/kg, classifying it as practically non-toxic upon single ingestion.[46]
• Subchronic and Chronic Toxicity: Long-term studies have confirmed its safety. A 90-day oral gavage study in multiple species (mice, rats, dogs, and monkeys) using methylcellulose (a closely related polymer) as a control at 20 mg/kg showed no adverse effects.[48] A 6-month chronic toxicity study in rats using a related compound, hydroxypropylmethylcellulose acetate succinate (HPMCAS), at oral doses up to 2.5 g/kg per day, found no significant dose-related behavioral, biochemical, or physiological abnormalities.[50]
• Mutagenicity and Carcinogenicity: Hypromellose has been shown to be non-mutagenic in standard genotoxicity tests, including the in vitro bacterial reverse mutation (Ames) assay.[7] It is not listed as a carcinogen by major regulatory and research bodies, including the National Toxicology Program (NTP), the International Agency for Research on Cancer (IARC), or the Occupational Safety and Health Administration (OSHA).[46]
• Reproductive and Developmental Toxicity: While specific fertility studies with Hypromellose have not been conducted, studies in rats fed diets containing up to 5% methylcellulose showed no significant adverse effects on reproductive function.[7]

6.5 Global Regulatory Status and Handling Guidelines

Hypromellose enjoys a broad and well-established regulatory acceptance across the globe for a variety of uses, reflecting its strong safety profile.

• In the United States, the FDA has approved Hypromellose for multiple applications. It is listed as a food additive permitted for direct addition to food for human consumption under 21 CFR 172.874.[9] For ophthalmic use, it is recognized as a safe and effective over-the-counter (OTC) demulcent at concentrations ranging from 0.2% to 2.5% under 21 CFR 349.12.[7]
• It is also approved for use as a food additive in the European Union.[9]
• The Joint FAO/WHO Expert Committee on Food Additives (JECFA) has evaluated Hypromellose and established an acceptable daily intake (ADI) of "not specified," a designation given to substances of very low toxicity for which the total dietary intake arising from their use at levels necessary to achieve the desired effect is not considered to represent a hazard to health.[9]

For occupational handling of Hypromellose powder, standard industrial hygiene and safety practices are recommended. This includes using eye protection (e.g., safety glasses) to prevent irritation from airborne dust and avoiding the generation of excessive dust, which can pose a minimal explosion risk, as is the case with many fine organic powders.[10]

7.0 Commercial and Formulation Landscape

7.1 Marketed Formulations and Brand Names

Hypromellose is a globally marketed product, available under a multitude of brand names, primarily as an ophthalmic lubricant for dry eye relief. In the United States, some of the most common over-the-counter brand names include Genteal, Isopto Tears, Nature's Tears, Gonak, Goniovisc, and Cellugel.[2]

Many commercial formulations are not single-agent products but are combination therapies that include other ophthalmic demulcents or lubricants to achieve specific rheological properties and enhance patient comfort. Common co-formulants include Dextran 70, carboxymethylcellulose, glycerin, povidone, and polyethylene glycol 400.[37] The international market for Hypromellose is extensive, with prominent brands such as

Artelac, Tears Naturale, and Hyprosan available in numerous countries across Europe, Asia, and other regions.[56] The sheer number and variety of available products underscore its status as a standard-of-care therapy for dry eye conditions worldwide.

Table 3: Selected International Brand Names of Hypromellose Ophthalmic Preparations

Brand Name	Active Ingredients	Key Regions / Countries of Availability
Artelac	Hypromellose	Europe (Germany, UK, France), Latin America (Brazil, Mexico), Asia (Philippines)
Tears Naturale	Hypromellose, Dextran 70	Global (Europe, Asia, North America)
Bion Tears	Hypromellose, Dextran 70	Asia (China, Hong Kong), Australia, New Zealand, Sweden
GenTeal	Hypromellose, Carbomer (in some formulations)	Global (North America, Latin America, Asia, Israel)
Isopto Tears	Hypromellose	North America (Canada), Europe (UK, Belgium), Asia (Hong Kong)
Hyprosan	Hypromellose	Nordic Countries (Denmark, Finland, Sweden, Norway)
Cellugel	Hypromellose	Germany, Australia
Dacriosol	Hypromellose, Dextran	Europe (Italy, Denmark)
Data compiled from various sources listing international brand names.56

7.2 Key Manufacturers and Suppliers

The production and supply of pharmaceutical-grade Hypromellose are handled by several major global chemical and pharmaceutical ingredient manufacturers. These companies produce a wide range of HPMC grades that comply with pharmacopeial standards such as the USP and Ph. Eur., as well as food-grade standards (FCC). Key suppliers in the market include:

• Ashland: A major producer that markets its HPMC products under the Benecel™ brand name, offering a comprehensive portfolio of grades for controlled release, film coating, and other applications.[21]
• JRS Pharma: This company supplies Hypromellose under the VIVAPHARM® brand, focusing on grades for film coating, wet granulation, and capsule manufacturing.[57]
• Spectrum Chemical Mfg. Corp.: A supplier offering a wide variety of Hypromellose grades that meet USP and FCC specifications, suitable for both pharmaceutical and food applications.[58]
• Other notable suppliers providing various grades of Hypromellose for research and manufacturing include Thermo Scientific Chemicals, Silver Fern Chemical, Medisca, and Selleck Chemicals.[58]

These manufacturers provide the critical raw material that enables the formulation of countless pharmaceutical products, from simple artificial tears to complex, once-daily oral medications.

8.0 Conclusion and Future Perspectives

Hypromellose (Hydroxypropyl Methylcellulose) has firmly established itself as an indispensable polymer in modern medicine and pharmaceutical technology. Its value is derived not from complex pharmacological activity, but from a highly predictable and versatile set of physicochemical properties. The direct, engineerable relationship between its molecular structure—namely, its degree of substitution and molecular weight—and its functional performance in areas like viscosity modification and gel formation allows it to be precisely tailored for a multitude of applications. This structure-function paradigm is the unifying principle that explains its dual success as both a safe and effective therapeutic agent for dry eye disease and as a foundational excipient for sophisticated drug delivery systems.

Its role as an ophthalmic demulcent is predicated on its ability to mimic and stabilize the natural tear film, providing sustained lubrication and protection to the ocular surface. As a pharmaceutical excipient, its dominance in the field of controlled-release oral formulations is unparalleled, enabling the development of medications with improved therapeutic profiles and patient compliance. The exceptional safety profile of Hypromellose, rooted in its complete biological inertness and lack of systemic absorption, is a critical asset that permits its widespread use in high concentrations without contributing to systemic toxicity or drug interactions.

Looking forward, the very properties that have made Hypromellose a staple of current pharmaceutical practice position it as an ideal candidate for next-generation drug delivery technologies. Its biocompatibility, gelling capacity, and film-forming characteristics are being actively explored for more advanced applications. These include the development of mucoadhesive films for buccal, nasal, or ocular drug delivery, which could enhance local drug concentration and bioavailability.[5] Its use as a hydrogel scaffold for wound healing and tissue engineering is another promising area of research.[5] Furthermore, as the industry moves towards personalized medicine, the unique properties of Hypromellose make it a prime material for emerging manufacturing techniques like 3D printing of customized dosage forms. The continued investigation into its various grades, its modification, and its combination with other novel polymers will undoubtedly unlock new therapeutic possibilities, ensuring that Hypromellose remains a vital and evolving tool in the advancement of pharmaceutical science for the foreseeable future.

Works cited

1. Hypromellose - Wikipedia, accessed August 18, 2025, https://en.wikipedia.org/wiki/Hypromellose
2. Hypromellose: Uses, Interactions, Mechanism of Action | DrugBank ..., accessed August 18, 2025, https://go.drugbank.com/drugs/DB11075
3. Hydroxypropyl Methylcellulose—A Key Excipient in Pharmaceutical Drug Delivery Systems, accessed August 18, 2025, https://www.pharmaexcipients.com/news/hpmc-key-excipient/
4. What is Hypromellose used for? - Patsnap Synapse, accessed August 18, 2025, https://synapse.patsnap.com/article/what-is-hypromellose-used-for
5. The use of Hypromellose in oral drug delivery - ResearchGate, accessed August 18, 2025, https://www.researchgate.net/publication/7840944_The_use_of_Hypromellose_in_oral_drug_delivery
6. Hydroxy Propyl Methyl Cellulose: Different Aspects in Drug Delivery - ResearchGate, accessed August 18, 2025, https://www.researchgate.net/publication/305781832_Hydroxy_Propyl_Methyl_Cellulose_Different_Aspects_in_Drug_Delivery
7. eCopy, Inc. - FDA, accessed August 18, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022193s000_PharmR.pdf
8. Pharmacology of Hydroxypropyl Methylcellulose (Hydromellose) ; Mechanism of action, Pharmacokinetics - YouTube, accessed August 18, 2025, https://www.youtube.com/watch?v=o-lC9Q3llgM
9. Safety assessment of hydroxypropyl methylcellulose as a food ingredient - PubMed, accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/17723258/
10. HPMC a biomedical polymer in pharmaceutical dosage forms, accessed August 18, 2025, https://www.jchps.com/issues/Volume%208_Issue%204/jchps%208(4)%2053%20Chinmaya%20keshari%20sahoo.pdf
11. SID 347911105 - PubChem, accessed August 18, 2025, https://pubchem.ncbi.nlm.nih.gov/substance/347911105
12. (Hydroxypropyl)methyl cellulose | CAS 9004-65-3 | SCBT - Santa Cruz Biotechnology, accessed August 18, 2025, https://www.scbt.com/p/hydroxypropyl-methyl-cellulose-9004-65-3
13. Hydroxypropyl Methylcellulose: Cosmetic Ingredient INCI - SpecialChem, accessed August 18, 2025, https://www.specialchem.com/cosmetics/inci-ingredients/hydroxypropyl-methylcellulose
14. Hydroxypropyl Methylcellulose—A Key Excipient in Pharmaceutical ..., accessed August 18, 2025, https://www.mdpi.com/1999-4923/17/6/784
15. Hydroxypropyl methyl cellulose: Application, metabolism and pharmacokinetics, accessed August 18, 2025, https://www.chemicalbook.com/article/hydroxypropyl-methyl-cellulose-application-metabolism-and-pharmacokinetics.htm
16. Hypromellose (HPMC) Chemical Characterization Services - Excipia, accessed August 18, 2025, https://www.excipia.eu/excipients/cellulose-derivatives/hypromellose/
17. en.wikipedia.org, accessed August 18, 2025, https://en.wikipedia.org/wiki/Hypromellose#:~:text=6%20External%20links-,Chemistry,react%20vigorously%20with%20oxidizing%20agents.
18. Hydroxypropyl methyl cellulose | 9004-65-3 - ChemicalBook, accessed August 18, 2025, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB3225318.htm
19. Hydroxypropyl Methylcellulose—A Key Excipient in Pharmaceutical Drug Delivery Systems, accessed August 18, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC12196896/
20. Hypromellose - US Pharmacopeia (USP), accessed August 18, 2025, https://www.usp.org/sites/default/files/usp/document/harmonization/excipients/hypromellose_monograph.pdf
21. Product Grades Available - Ashland, accessed August 18, 2025, https://www.ashland.com/file_source/Ashland/Industries/Pharmaceutical/Links/PC-11608.12_Pharma_Product_Grades.pdf
22. How to Choose the Right HPMC Viscosity for Different Applications, accessed August 18, 2025, https://www.hpmcfactory.com/news-choose-right-hpmc-viscosity-for-different-applications.html
23. The Ultimate HPMC Grades Breakdown - Construction Chemical Manufacturer and Supplier in China, accessed August 18, 2025, https://wotaichem.com/hpmc-grades-breakdown/
24. What is the mechanism of Hypromellose? - Patsnap Synapse, accessed August 18, 2025, https://synapse.patsnap.com/article/what-is-the-mechanism-of-hypromellose
25. Artificial Tears (Hypromellose): Uses, Side Effects, Interactions, Pictures, Warnings & Dosing, accessed August 18, 2025, https://www.webmd.com/drugs/2/drug-32846/artificial-tears-hypromellose/details
26. Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006 - E-lactancia, accessed August 18, 2025, https://www.e-lactancia.org/media/papers/Hypromellose-DS-MHRA2009.pdf
27. use of hypromellose in oral drug delivery | Journal of Pharmacy and Pharmacology | Oxford Academic, accessed August 18, 2025, https://academic.oup.com/jpp/article/57/5/533/6147544
28. Hypromellose API Manufacturers | GMP-Certified Suppliers - Pharmaoffer.com, accessed August 18, 2025, https://pharmaoffer.com/api-excipient-supplier/hypromellose
29. Hydroxypropyl Methylcellulose-A Key Excipient in Pharmaceutical Drug Delivery Systems, accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/40574096/
30. Hydroxypropyl cellulose: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed August 18, 2025, https://go.drugbank.com/drugs/DB00840
31. Hypromellose Eye Drops BPC 0.3% - Summary of Product ..., accessed August 18, 2025, https://www.medicines.org.uk/emc/product/3537/smpc
32. Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination | Goodman & Gilman's: The Pharmacological Basis of Therapeutics, 13e | AccessMedicine, accessed August 18, 2025, https://accessmedicine.mhmedical.com/content.aspx?aid=1162532708
33. Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems - PMC, accessed August 18, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6806371/
34. PHARMACOLOGY REVIEW(S) - accessdata.fda.gov, accessed August 18, 2025, https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022210s000pharmr.pdf
35. Hypromellose (ophthalmic route) - Side effects & dosage - Mayo Clinic, accessed August 18, 2025, https://www.mayoclinic.org/drugs-supplements/hypromellose-ophthalmic-route/description/drg-20064245
36. Hypromellose 0.3% w/v Eye Drops (FAMAR) - Patient Information ..., accessed August 18, 2025, https://www.medicines.org.uk/emc/product/9455/pil
37. artificial tears (hypromellose) 0.5 % eye drops - Kaiser Permanente, accessed August 18, 2025, https://healthy.kaiserpermanente.org/health-wellness/drug-encyclopedia/drug.artificial-tears-hypromellose-0-5-eye-drops.297857
38. Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome - PubMed, accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/17868503/
39. www.mayoclinic.org, accessed August 18, 2025, https://www.mayoclinic.org/drugs-supplements/hypromellose-intraocular-route/description/drg-20064230#:~:text=Hypromellose%20is%20used%20as%20a,damage%20due%20to%20surgical%20instruments.
40. Hypromellose (intraocular route) - Side effects & uses - Mayo Clinic, accessed August 18, 2025, https://www.mayoclinic.org/drugs-supplements/hypromellose-intraocular-route/description/drg-20064230
41. Hypromellose ophthalmic Uses, Side Effects & Warnings - Drugs.com, accessed August 18, 2025, https://www.drugs.com/mtm/hypromellose-ophthalmic.html
42. Hypromelloses: What is it and where is it used? - Drugs.com, accessed August 18, 2025, https://www.drugs.com/inactive/hypromelloses-447.html
43. Hypromellose Completed Phase 4 Trials for Glaucoma / Ocular Hypertension Treatment | DrugBank Online, accessed August 18, 2025, https://go.drugbank.com/drugs/DB11075/clinical_trials?conditions=DBCOND0010013%2CDBCOND0074237&phase=4&purpose=treatment&status=completed
44. Hypromellose Unknown Status Phase 2 Trials for Dry Eye Syndrome (DES) / Dry Eyes Treatment | DrugBank Online, accessed August 18, 2025, https://go.drugbank.com/drugs/DB11075/clinical_trials?conditions=DBCOND0074986%2CDBCOND0054254&phase=2&purpose=treatment&status=unknown_status
45. Gonak Hypromellose Uses, Side Effects & Warnings - Drugs.com, accessed August 18, 2025, https://www.drugs.com/mtm/gonak-hypromellose.html
46. SDS: GONAK™ Hypromellose Ophthalmic Demulcent ... - Medline, accessed August 18, 2025, https://www.medline.com/media/catalog/Docs/MSDS/MSD_SDSD12943.pdf
47. hypromellose ophthalmic - St. Luke's, accessed August 18, 2025, https://www.stlukesonline.org/health-services/health-information/healthwise/2019/09/26/21/03/hypromellose-ophthalmic
48. Comprehensive Investigation of Hydroxypropyl Methylcellulose, Propylene Glycol, Polysorbate 80, and Hydroxypropyl-Beta-Cyclodextrin for use in General Toxicology Studies | Request PDF - ResearchGate, accessed August 18, 2025, https://www.researchgate.net/publication/45274919_Comprehensive_Investigation_of_Hydroxypropyl_Methylcellulose_Propylene_Glycol_Polysorbate_80_and_Hydroxypropyl-Beta-Cyclodextrin_for_use_in_General_Toxicology_Studies
49. Comprehensive Investigation of Hydroxypropyl Methylcellulose, Propylene Glycol, Polysorbate 80, and Hydroxypropyl-Beta-Cyclodextrin for use in General Toxicology Studies - Oxford Academic, accessed August 18, 2025, https://academic.oup.com/toxsci/article/117/2/485/1641380
50. Toxicological studies of hydroxypropylmethylcellulose acetate ..., accessed August 18, 2025, https://pubmed.ncbi.nlm.nih.gov/3841672/
51. toxicological studies of hydroxypropylmethylcellulose acetate succinate : acute toxicity in rats and rabbits, and subchronic and chronic toxicities in - J-Stage, accessed August 18, 2025, https://www.jstage.jst.go.jp/article/jts1976/10/SupplementII/10_SupplementII_147/_article
52. Hydroxypropyl methylcellulose - brand name list from Drugs.com, accessed August 18, 2025, https://www.drugs.com/ingredient/hydroxypropyl-methylcellulose.html
53. Tetrahydrozoline/Zinc Sulfate/Hypromellose: Dry Eye Uses - MedicineNet, accessed August 18, 2025, https://www.medicinenet.com/tetrahydrozoline_zinc_sulfate_hypromellose_ophthal/article.htm
54. Genteal Lubricant Eye Drops Moderate-to-Severe (hypromellose/carboxymethylcellulose ophthalmic) dosing, indications, interactions, adverse effects, and more - Medscape Reference, accessed August 18, 2025, https://reference.medscape.com/drug/genteal-lubricant-eye-drops-moderate-to-severe-hypromellose-carboxymethylcellulose-ophthalmic-1000103
55. dextran 70-hypromellose (PF) 0.1 %-0.3 % eye drops in a dropperette | Kaiser Permanente, accessed August 18, 2025, https://healthy.kaiserpermanente.org/health-wellness/drug-encyclopedia/drug.dextran-70-hypromellose-pf-0-1-0-3-eye-drops-in-a-dropperette.559113
56. Hypromellose (International database) - Drugs.com, accessed August 18, 2025, https://www.drugs.com/international/hypromellose.html
57. VIVAPHARM® HPMC - JRS Pharma, accessed August 18, 2025, https://www.jrspharma.com/pharma_en/products/coatings/vivapharm-hpmc.php
58. 11 results for Hydroxypropyl methyl cellulose (Hypromellose) - Avantor, accessed August 18, 2025, https://www.avantorsciences.com/us/en/category/8907539/hydroxypropyl-methyl-cellulose-hypromellose
59. Hypromellose | 99%(HPLC) | In Stock | Others - Selleck Chemicals, accessed August 18, 2025, https://www.selleckchem.com/products/hypromellose.html
60. Hypromellose Methylcellulose Supplier | 9004-65-3 | Your Reliable Distributor Silver Fern, accessed August 18, 2025, https://www.silverfernchemical.com/chemical-supplier-9004-65-3/hypromellose-methylcellulose-hpmc-distributor-1659.aspx
61. Hypromellose, USP (100000mPa.s) | Excipient - Medisca, accessed August 18, 2025, https://www.medisca.com/products/hypromellose-usp-100000mpa-s